1. Home
  2. DERM vs SSSS Comparison

DERM vs SSSS Comparison

Compare DERM & SSSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DERM
  • SSSS
  • Stock Information
  • Founded
  • DERM 2014
  • SSSS 2010
  • Country
  • DERM United States
  • SSSS United States
  • Employees
  • DERM N/A
  • SSSS N/A
  • Industry
  • DERM Biotechnology: Pharmaceutical Preparations
  • SSSS Finance: Consumer Services
  • Sector
  • DERM Health Care
  • SSSS Finance
  • Exchange
  • DERM Nasdaq
  • SSSS Nasdaq
  • Market Cap
  • DERM 190.7M
  • SSSS 228.1M
  • IPO Year
  • DERM 2021
  • SSSS N/A
  • Fundamental
  • Price
  • DERM $7.94
  • SSSS $9.07
  • Analyst Decision
  • DERM Strong Buy
  • SSSS Strong Buy
  • Analyst Count
  • DERM 3
  • SSSS 4
  • Target Price
  • DERM $12.67
  • SSSS $9.75
  • AVG Volume (30 Days)
  • DERM 153.4K
  • SSSS 213.9K
  • Earning Date
  • DERM 11-07-2025
  • SSSS 11-04-2025
  • Dividend Yield
  • DERM N/A
  • SSSS 11.07%
  • EPS Growth
  • DERM N/A
  • SSSS N/A
  • EPS
  • DERM N/A
  • SSSS 2.22
  • Revenue
  • DERM $56,397,000.00
  • SSSS $2,784,381.00
  • Revenue This Year
  • DERM $26.16
  • SSSS $7,183.09
  • Revenue Next Year
  • DERM $45.27
  • SSSS N/A
  • P/E Ratio
  • DERM N/A
  • SSSS $4.06
  • Revenue Growth
  • DERM N/A
  • SSSS N/A
  • 52 Week Low
  • DERM $3.54
  • SSSS $4.21
  • 52 Week High
  • DERM $8.90
  • SSSS $10.05
  • Technical
  • Relative Strength Index (RSI)
  • DERM 66.43
  • SSSS 48.31
  • Support Level
  • DERM $7.38
  • SSSS $8.80
  • Resistance Level
  • DERM $8.20
  • SSSS $9.09
  • Average True Range (ATR)
  • DERM 0.36
  • SSSS 0.26
  • MACD
  • DERM 0.09
  • SSSS -0.04
  • Stochastic Oscillator
  • DERM 93.80
  • SSSS 27.30

About DERM Journey Medical Corporation

Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's current product portfolio includes eight FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others.

About SSSS SuRo Capital Corp.

SuRo Capital Corp is a non-diversified closed-end management investment company. The company's investment objective is to maximize its portfolio's total return, principally by seeking capital gains on its equity and equity-related investments.

Share on Social Networks: